Ultrastructural, cytogenetic, and molecular findings in mast cell leukemia: Case report

Autor: Anna Bosch‐Vilaseca, Anna Monter‐Rovira, Sabina Cisa‐Wieczorek, Guadalupe Oñate, Elena Bussaglia, Maite Carricondo, Ángel Remacha, Clara Martínez, Marta Pratcorona, María Laura Blanco, Josep F. Nomdedéu

Publikováno v: Clinical Case Reports, Vol 7, Iss 7, Pp 1395-1398 (2019)

Abstract We report a de novo aleukemic form of MCL with a complex monosomic karyotype with LOH for multiple chromosomes and TP53 mutation. Additionally, whereas D816V KIT was not found, the c‐Kit transmembrane domain p.M541L variant was detected wh

Externí odkaz: https://doaj.org/article/11cb06dd9817495db4d89bd71d9eb7bb

Feasibility of thiotepa addition to the fludarabine-busulfan conditioning with tacrolimus/sirolimus as graft vs host disease prophylaxis

Autor: José Luis Piñana, Francesc Bosch, Guillermo Ortí, Irene García-Cadenas, Albert Esquirol, Anna Bosch Vilaseca, Olga Salamero, Elisa Roldán, Jordi Sierra, Silvana Saavedra, Pere Barba, Maria Laura Fox, Guillermo Villacampa, Juan Montoro, Rodrigo Martino, Jaime Sanz, Ariadna Pérez, Juan Carlos Hernández-Boluda, Carlos Solano, David Valcárcel

Publikováno v: LEUKEMIA & LYMPHOMA
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Leukemia & lymphoma
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe

In classical reduced-intensity conditioning (RIC) regimens, including the fludarabine and busulphan (BF) combination, sirolimus and tacrolimus (SIR-TAC) as graft vs host disease (GVHD) prophylaxis has shown acceptable results. The outcomes of SIR-TAC

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9059450a8457ce593110d89fbb906778
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=4681

Incorporating posttransplant cyclophosphamide-based prophylaxis as standard-of-care outside the haploidentical setting: challenges and review of the literature

Autor: Silvana Saavedra, Javier Briones, Salut Brunet, Rodrigo Martino, Irene García-Cadenas, Jordi Mas López, Anna Bosch-Vilaseca, Silvana Novelli, Albert Esquirol, Carol Moreno, R. Awol, Jordi Sierra, Anna Garrido, Miquel Granell

Publikováno v: Bone marrow transplantation. 55(6)

Posttransplant high-dose cyclophosphamide (PTCy) effectively prevents GvHD after haploidentical SCT. However, its use in HLA-matched SCT has been less explored. Fifty-six consecutive patients who underwent allo-SCT for hematological malignancies have

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bf82a597e143a4fe8d75027b58b2d4d
https://pubmed.ncbi.nlm.nih.gov/31822813

Patterns of infection and infectious-related mortality in patients receiving post-transplant high dose cyclophosphamide as graft-versus-host-disease prophylaxis: impact of HLA donor matching

Autor: Irene, García-Cadenas, Albert, Esquirol, Anna, Bosch-Vilaseca, Rahinatu, Awol, Silvana, Novelli, Silvana, Saavedra, Ana, Garrido, Jordi, López, Carolina, Caballero Ana, Miquel, Granell, Carolina, Moreno, Javier, Briones, Jorge, Sierra, Rodrigo, Martino

Publikováno v: Bone Marrow Transplantation; April 2021, Vol. 56 Issue: 4 p818-827, 10p